|
|
|
|
LEADER |
01079caa a2200301 ir4500 |
001 |
NSK01000037746 |
003 |
HR-ZaNSK |
005 |
20170301160015.0 |
008 |
940217s1995 ci ||| ||eng |
015 |
|
|
|a HP95-0949
|2 HR
|
035 |
|
|
|9 (HR-ZaNSK)37783
|
035 |
|
|
|9 (HR-ZaNSK)940217179
|
035 |
|
|
|a (HR-ZaNSK)000037746
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
041 |
0 |
|
|a eng
|b hrv
|
080 |
|
|
|a 615:577.213
|2 MRF 2011.
|
080 |
|
|
|a 577.213:615
|2 MRF 2011.
|
100 |
1 |
|
|a Delić, Vladimir,
|c biokemičar
|
245 |
1 |
0 |
|a Some applications of recombinant DNA technology in pharmaceutical industry /
|c Vladimir Delić.
|
300 |
|
|
|b Ilustr.
|
500 |
|
|
|a First conference on biotechnology of Central European Initiative Countries, Graz, 13-15. April, 1992.
|
504 |
|
|
|a Bibliografija: 25 jed
|
504 |
|
|
|a Sažetak
|
653 |
0 |
|
|a Rekombinantna DNK
|a Farmaceutska industrija
|
773 |
0 |
|
|t Medicus (Zagreb. 1992)
|x 1330-013X
|g 2 (1993), 1 ; str. 85-101
|w nsk.(HR-ZaNSK)000012765
|
981 |
|
|
|p CRO
|z B2/95
|
998 |
|
|
|c IMH, 199610
|c ika, 970807
|
886 |
0 |
|
|2 unimarc
|b 00785iaa2 2200229 450
|